Drug recall · September 29, 2021
Zonisamide 100 mg Capsules recall
Why: CGMP deviations: Gaps in the quality system in the Quality Control microbiology laboratory.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Zonisamide 100 mg Capsules, 30-count bottles, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534 Mfg. For Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, NDC 61919-0775-30
- Lots / codes
Lot #: 17JU2118 Exp. 5/31/23
- Quantity
- 2 bottles
- Company
- Direct Rx, Dawsonville, GA
- Distribution
- FL only
- Initiated
- September 14, 2021 · Voluntary: Firm initiated
- Classified
- September 23, 2021
- Reported
- September 29, 2021
- Ended
- October 22, 2021
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Zonisamide
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.